Mechanisms and Treatment of Cancer-Related Symptoms Conf

描述（由申请人提供）：癌症症状通常是孤立研究的;然而，它们显然是一起发生的，它们可能会加剧彼此的严重程度。 越来越多的人意识到，共同的生物学机制可能会同时导致或促成其中一些症状。 此应用程序请求NIH支持一个名为“癌症相关症状的机制和治疗”的会议。" 第二届癌症症状年会由德克萨斯大学M。D.安德森癌症中心，将研究疼痛，疲劳，睡眠障碍和认知功能障碍之间的关系。 它将在人类研究和动物模型的讨论中探索这些症状的潜在共同生物学机制。 这次会议的具体目标是： .促进症状研究的新兴领域，将动物和人类研究结合在癌症症状的综合方法中 .为基础科学和临床研究的学员提供年度学习场所 .为目前参与症状研究的科学家提供互动和交流思想的机会 这次会议将是有价值的基础科学家，临床研究人员，肿瘤学家，临床护士，神经心理学家，神经学家，精神病学家和心理学家，和生物免疫治疗师。 与会者将学习最新的使用成像作为工具，探索非特异性症状的基础。 会议还将审查最新的遗传药理学的相关治疗。 这次会议也应该引起正在开发用于症状控制和支持性护理的“管道”药物的制药公司的兴趣。

DESCRIPTION (provided by applicant): Cancer symptoms are most often studied in isolation; however, they clearly occur together, and they may exacerbate the severity of one another. There is growing awareness that common biologic mechanisms may cause or contribute to some of these symptoms at the same time. This application is requesting NIH support for a conference entitled "Mechanisms and Treatment of Cancer-Related Symptoms." The second annual conference on cancer symptoms, organized by the Department of Symptom Research, at The University of Texas M. D. Anderson Cancer Center, will examine the relationships among pain, fatigue, sleep disturbance, and cognitive dysfunction. It will explore, in discussions of both human studies and animal models, the potential common biologic mechanisms of these symptoms. Specific aims of this conference are to: . Promote the emerging field of symptom research, combining animal and human research in an integrated approach to cancer symptoms . Provide an annual learning venue for trainees in both the basic sciences and clinical investigation . Provide an opportunity for interaction and exchange of ideas among scientists currently involved in symptom research This conference will be of value to basic scientists, clinical researchers, oncologists, nurse clinicians, neuropsychologists, neurologists, psychiatrists and psychologists, and bioimmunotherapists. Attendees will learn the latest in the use of imaging as a tool for exploration of the basis of non-specific symptoms. The conference will also examine the latest in the pharmacogenetics of symptom-related therapies. The conference should also be of interest to pharmaceutical companies that are developing "pipeline" drugs for symptom control and supportive care.